Navigating Clinical Trials Amidst Global Challenges
In a world marked by unpredictability, how do we ensure that critical clinical studies remain unshaken? Dive deep into the resilience and adaptability showcased by Site Enablement:
- Business Continuity: Understand how Site Enablement has been a cornerstone in ensuring that operations continue seamlessly, even in the face of global crises.
- Bridging Gaps with Technology: Explore the revolutionary potential of connecting sites and sponsors using state-of-the-art technology, ensuring that no trial is left behind.
- Real-World Resilience: Delve into tangible use cases that demonstrate the transformative impact of Site Enablement in challenging times.
Speaker Spotlight: Kateryna Orlovska, Country Clinical Quality Manager at Merck, will share her unique perspective. Drawing from her experiences in Ukraine, Kateryna will shed light on the symbiotic relationship between human determination and technological innovation. Her narrative promises a profound reflection on how, even amidst adversities, technology and processes can work hand-in-hand to ensure that clinical trials progress, cures advance, and patient safety remains paramount. Join us for an inspiring journey of perseverance, innovation, and hope.
Kateryna Orlovska – Clinical Quality Operations Manager, MSD
Lilith Mist – Executive Clinical Research Director, Merck
Ryan Jones – CEO, Florence
Catherine Gregor – CCTO, Florence